Drugs Archives - Page 8 of 66

Harris in the Spotlight

Episode 357

July 25, 2024

For the 2024 campaign, Joe Biden is out, and Kamala Harris is in. As the vice president makes moves toward the top of the Democratic presidential ticket, health policy is resurging as a campaign issue. Meanwhile, Congress tries — and again fails — to make timely progress on the annual government spending bills as abortion issues cause delays. Alice Miranda Ollstein of Politico, Stephanie Armour of KFF Health News, and Rachel Cohrs Zhang of Stat join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Anthony Wright, the new executive director of Families USA, about his plans for the organization and his history working with Harris on health topics. 

Listen Now

A photo of the exterior of Wall Drug's complex.

Postcard From South Dakota

World-Famous Wall Drug Isn’t Immune From Challenges Facing Rural Pharmacies

Even as part of a popular South Dakota tourist attraction, an independent pharmacy serving locals, remote ranchers, and sightseers struggles with staffing and insurer payments.

By Arielle Zionts

July 24, 2024

A photo of boxes of mifepristone and next to a pill bottle of misoprostol.

Louisiana Reclassifies Drugs Used in Abortions as Controlled Dangerous Substances

Louisiana lawmakers have added two drugs commonly used in pregnancy and reproductive health care to the state’s list of controlled dangerous substances, a move that has alarmed doctors in the state.

By Rosemary Westwood, WWNO

July 24, 2024

An illustration drawn with pencil and colored digitally shows a scientist-type man in the center of the image. He holds two halves of an Ozempic-like injector in his gloved hands and pours a mysterious liquid from one side to the other. Behind him, corporate copycats, drawn as floating heads and hands, watch to steal his formula while they manipulate their own mysterious liquid. The floating copycats repeat into the background.

Why Millions Are Trying FDA-Authorized Alternatives to Big Pharma’s Weight Loss Drugs

Although Novo Nordisk and Lilly lump together the pharmacies that compound semaglutide and tirzepatide with internet cowboys selling fake drugs, there is a distinction. The FDA has offered Americans little clarity about the vast gray and black markets for the drugs.

By Arthur Allen

July 23, 2024

A photo of Kamala Harris on a stage in front of a podium with a microphone.

Elections

Harris, Once Biden’s Voice on Abortion, Would Take an Outspoken Approach to Health

If she grabs the baton from President Joe Biden to become the new presumptive Democratic presidential nominee, Kamala Harris would widely be expected to take an aggressive stance in support of abortion access — hitting former President Donald Trump on an issue that could undermine his chances of victory.

By Stephanie Armour, Julie Appleby, and Julie Rovner

July 21, 2024

A photo of the Supreme Court's exterior at sunrise.

The Supreme Court Just Limited Federal Power. Health Care Is Feeling the Shockwaves.

A Supreme Court ruling restricting federal power will likely have seismic ramifications for health policy. A flood of litigation — with plaintiffs like small businesses, drugmakers, and hospitals challenging regulations they say are too expensive or burdensome and not authorized by law — could leave the country with a patchwork of disparate health regulations.

By Stephanie Armour

July 1, 2024

1st Biden-Trump Debate of 2024: What They Got Wrong, and Right

A debate marked by President Joe Biden’s faltering performance featured clashes over insulin costs, inflation, abortion, immigration, and Jan. 6.

By KFF Health News and PolitiFact staffs

June 28, 2024

What the Health? From KFF Health News

SCOTUS Rejects Abortion Pill Challenge — For Now

Episode 351

June 13, 2024

The Supreme Court has dismissed a challenge to the FDA’s approval of the abortion pill mifepristone, ruling unanimously that the anti-abortion doctor group that filed the suit lacked standing. But abortion opponents are expected to pursue other strategies to ban or restrict the medication. Meanwhile, the Biden administration moves to stop the inclusion of medical debt on individual credit reports, and former President Donald Trump tries to claim credit for $35 insulin. Anna Edney of Bloomberg News, Rachana Pradhan of KFF Health News, and Emmarie Huetteman of KFF Health News join KFF Health News chief Washington correspondent Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF president and CEO Drew Altman about KFF’s new “Health Policy 101” primer.

Listen Now

Vertical images of three men, side by side. the first poses for the camera wearing a shirt and tie; second wearing a blue polo and smiling in front of shelves of prescriptions; third wearing a white coat and glasses, smiling in front of shelves of prescriptions.

Biden Plan To Save Medicare Patients Money on Drugs Risks Empty Shelves, Pharmacists Say

President Joe Biden is campaigning for reelection on his efforts to cut costs for Medicare patients at the pharmacy counter. But independent pharmacists say one strategy makes it unaffordable for them to keep some brand-name medicines in stock.

By Susan Jaffe

June 11, 2024

Health Brief

Weight-Loss Drugs Are So Popular They’re Headed for Medicare Negotiations

By Renuka Rayasam

June 7, 2024

Letters to the Editor

Readers Issue Rx for Clogged ERs and Outrageous Out-of-Pocket Costs

KFF Health News gives readers a chance to comment on a recent batch of stories.

June 3, 2024

KFF Health News On Air

Journalists Talk Cost of Weight Loss Drugs and Lack of Obesity Doctors to Manage Their Use

KFF Health News and California Healthline staff made the rounds on national and local media this week to discuss topical stories. Here’s a collection of their appearances.

June 1, 2024

What the Health? From KFF Health News

Waiting for SCOTUS

Episode 349

May 30, 2024

June is when the Supreme Court typically issues rulings in the major cases it hears during that year’s term. This year, those interested in health policy are awaiting decisions in two abortion-related cases and one that could reshuffle the way health policies (and all other federal policies) are made. In this special episode, KFF’s Laurie Sobel, associate director for women’s health policy, joins Julie Rovner for a review of the cases and a preview of how the court might rule.

Listen Now

An aerial photo shows the entrance and front parking lot of a hospital.

An Obscure Drug Discount Program Stifles Use of Federal Lifeline by Rural Hospitals

A disconnect between two federal programs meant to help keep hospitals afloat discourages struggling rural facilities from accepting the aid.

By Sarah Jane Tribble

May 30, 2024

KFF Health News On Air

Journalists Zero In on Bird Flu and Weight Loss Drugs

KFF Health News and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.

May 25, 2024

High Price of Popular Diabetes Drugs Deprives Low-Income People of Effective Treatment

The makers of Ozempic and Mounjaro charge list prices of around $1,000 a month for the diabetes and obesity drugs, and insurers are reluctant to pick up the tab. Often, low-income patients have to resort to less effective treatments.

By Renuka Rayasam

May 21, 2024

KFF Health News On Air

Journalists Broach Topics From Treating Shooting Victims to Sunscreen Safety

KFF Health News and California Healthline staffers made the rounds on national and local media in the last couple of weeks to discuss topical stories. Here’s a collection of their appearances.

May 18, 2024

Two people in a warehouse, a woman in a white cardigan and a man in a green cap, sort syringes into a large brown box in a church basement.

Clean Needles Save Lives. In Some States, They Might Not Be Legal.

As billions of dollars from settlements with opioid manufacturers and distributors go to state and local governments, efforts to reduce the epidemic’s harm can be hamstrung by drug paraphernalia laws. Health authorities say distributing clean syringes to users can save lives, but in states like Pennsylvania, it may be illegal.

By Ed Mahon, Spotlight PA and Sarah Boden, WESA

May 17, 2024

A digital illustration of differently shaped sunscreen containers lined up in front of a shining sun. The containers each have a flag on it, including those of the United States, the European Union, Japan, France, South Korea, Australia, and Canada.

What’s Keeping the US From Allowing Better Sunscreens?

A decade after Congress told the FDA to expedite the approval of more effective sunscreens, the federal government still has not approved sunscreen ingredients that are safely being used around the world. Meanwhile, skin cancer is the nation’s most common cancer.

By Michael Scaturro

May 7, 2024

Amgen Plows Ahead With Costly, Highly Toxic Cancer Dosing Despite FDA Challenge

The FDA told Amgen to test whether a quarter-dose of its lung cancer drug worked as well as the amount recommended on the product label. It did and with fewer side effects. But Amgen is sticking to the higher dose — which earns it an additional $180,000 a year per patient.

By Arthur Allen

May 7, 2024

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Drugs